Approved Hospital Formulary
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

iptacopan

iptacopan
Drug Name Form Strength Notes
Fabhalta CAPSULE, ORAL 200 mg


Additional Information:

pending May 2026 P&T Committee review

 

The goal of the Fabhalta REMS is to mitigate the risk serious infections caused by encapsulated bacteria, and includes health care provider, patient, pharmacy and wholesaler-distributor requirements for dispensing.

See Legacy Health REMS Requirements for detail. 


Last updated: Apr. 28, 2026







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.